The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients

References

• Susantitaphong P, Altamimi S, Ashkar M, et al. GFR at initiation of dialysis and mortality in CKD: A meta-analysis. Am J Kidney Dis. 2012;59(6):829–840
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305
   PubMed Web of Science ®Google Scholar
• Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–180
   PubMed Web of Science ®Google Scholar
• Perkins I. Diabetes mellitus epidemiology-classification, determinants and public health impacts. J Miss State Med Assoc. 2004;45(12):355–362
   PubMedGoogle Scholar
• Abe M, Okada K, Maruyama T, et al. Comparison of the effect of polysulfone and polyester-polymer alloy dialyzers on glycemic control in diabetic patients undergoing hemodialysis. Clin Nephrol. 2009;71(5):514–520
   PubMed Web of Science ®Google Scholar
• Abe M, Okada K, Maruyama T, et al. Clinical evaluation of plasma insulin and c-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis. Int J Artif Organs. 2008;31(10):898–904
   PubMed Web of Science ®Google Scholar
• Abe M, Okada K, İkeda K, Matsumoto S, Soma M, Matsumoto K. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis. Artif Organs. 2011;35(4):398–403
   PubMed Web of Science ®Google Scholar
• Abe M, Kikuchi F, Kaizu K, Matsumoto K. The Influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis. Clin Nephrol. 2008;69(5):354–360
   PubMed Web of Science ®Google Scholar
• Borzou SE, Gholyaf M, Zandiha M, Amini R, Goodarzi MT, Torkaman B. The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20(4):639–642
   PubMedGoogle Scholar
• Karkar A. Modalities of hemodialysis: Quality improvement. Saudi J Kidney Dis Transpl. 2012;23(6):1145–1161
   PubMedGoogle Scholar
• Hung AM, Ikizler TA. Factor determining insulin resistance in chronic hemodialysis patients. Diabetes Res Clin Pract. 2008;82(1):17–19
   Google Scholar
• Caravaca F, Cerezo I, Macias R, et al. Insulin resistance in chronic kidney disease: Its clinical characteristics and prognostic significance. Nefrologia. 2010;30(6):661–668
   PubMed Web of Science ®Google Scholar
• Bodlaj G, Bergi J, Pichler R Biesenbach G. Prevalence, severity and predictors of HOMA-estimated insulin resistance in diabetic and nondiabetic patients with end-stage renal disease. J Nephrol. 2006;19(5):607–612
   PubMed Web of Science ®Google Scholar
• Satirapoj B, Supasyndh O, Phanrtana-Andkul P. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes. J Med Assoc Thai. 2011;94(Suppl 4):S87–S93
   PubMedGoogle Scholar
• Sit D, Kadiroglu AK, Yılmaz ME, Kara IH, Isikoglu B. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Ren Fail. 2005;27(4):403–407
   PubMed Web of Science ®Google Scholar
• Niemzyk S, Szamaotulska K, Giers K, et al. Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients. Med Sci Monit. 2013;19:592–598
   PubMed Web of Science ®Google Scholar
• Thyago PM, Paulo Cesar NF, Silvia Carreira Ribeiro, Miguel CR, Roberto PF. Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic hemodialysis and peritoneal dialysis patients. J Brazil Nephrol. 2011;33(2):173–179
   Google Scholar
• Sit D, Kadiroglu AK, Yilmaz ME, Kara IH, Isikoglu B. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. J Renal Nutr. 2012;27:1051–1053
   Google Scholar
• Tseke P, Stamatelopoulos K, George R, Eirini G, Papamichael C, Nikalaos Z. HOMA-IR: A marker of vascular dysfunction in nondiabetic hemodialysis patients? Blood Purif. 2010;29:327–328
   PubMed Web of Science ®Google Scholar
• Allon M. Evidence-based cardiology in hemodialysis patients. J Am Soc Nephrol. 2013;24(12):1934–1943
   PubMed Web of Science ®Google Scholar
• Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106(4):453–458
   PubMed Web of Science ®Google Scholar
• Chu PL, Chia YL, Lin JW, Chen SI, Wu KD. Effect of low and high flux dialyzers on oxidative stress and insulin resistance. Renal Fail. 2005;27(4):403–407
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Y, Lv J, Wang M. Clinical outcomes for maintenance hemodialysis patients using a high-flux (FX60) dialyzer. Ren Fail. 2013;35(9):1240–1245
   PubMed Web of Science ®Google Scholar
• Chu PL, Chiu YL, Lin JW, Chen SI, Wu KD. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance. Blood Purif. 2008;26(2):213–220
   PubMed Web of Science ®Google Scholar
• Sobaszek-Pitas M, Kopeć J, Krzanowski M, Sułowicz W. Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-fluxhelixone dialyzers. Przegl Lek. 2014;71(7):384–388
   PubMedGoogle Scholar
• Azak A, Huddam B, Öneç K, et al. Contribution of high flux membranes to the therapy of uremia-associated dyslipidemia. Ther Apher Dial. 2012;16(6):595–599
   PubMed Web of Science ®Google Scholar